Cadrenal Therapeutics, Inc.
CVKD • NASDAQ
Cadrenal Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Quang X. Pham, with a market cap of $11.7M.
CEOQuang X. Pham
Next Earnings
Upcoming earnings announcement for Cadrenal Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in 3 weeks)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.72
Earnings History
Past 12 earnings reports for Cadrenal Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$1.41Est: -$1.19 | -18.5% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$1.31Est: -$1.72 | +23.8% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$1.87Est: -$1.71 | -9.4% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$2.09Est: -$2.15 | +2.8% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$2.80Est: -$1.87 | -49.7% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$2.18Est: -$1.93 | -13.0% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$2.25Est: -$1.20 | -87.5% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.50Est: -$1.05 | -42.9% | - | — | 10-Q |
| Mar 11, 2024 | Q4 2023 | -$0.75Est: -$1.20 | +37.5% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$1.05 | — | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$1.35 | — | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$7.20 | — | - | — | — |